Evidence map›Paper›PMID 40563581›Full record

ArticleCancers2025

Perioperative Systemic Therapy in Rare, Chemosensitive Subtypes of Retroperitoneal Sarcoma: A Hospital-Based Propensity Score-Matched Analysis.

Benjamin Wiesler, Laleh Forountani, Amir Ashraf Ganjouei, Lara Studerus, Christoph Kettelhack, Fatime Krasniqi, Benjamin Kasenda, Beat P Müller, Mohamed A Adam, Alexander Wilhelm

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Benjamin WieslerDepartment of Surgery, Clarunis-St. Clara Hospital & University Hospital Basel, 4031 Basel, Switzerland.ORCID 0000-0002-2994-0237
Laleh ForountaniDepartment of Surgery, University of California San Francisco, San Francisco, CA 94143, USA.
Amir Ashraf GanjoueiDepartment of Surgery, University of California San Francisco, San Francisco, CA 94143, USA.
Lara StuderusDepartment of Surgery, Clarunis-St. Clara Hospital & University Hospital Basel, 4031 Basel, Switzerland.ORCID 0009-0009-3868-7243
Christoph KettelhackDepartment of Surgery, Clarunis-St. Clara Hospital & University Hospital Basel, 4031 Basel, Switzerland.
Fatime KrasniqiDepartment of Medical Oncology, University Hospital Basel, 4031 Basel, Switzerland.
Benjamin KasendaDepartment of Medical Oncology, University Hospital Basel, 4031 Basel, Switzerland.
Beat P MüllerDepartment of Surgery, Clarunis-St. Clara Hospital & University Hospital Basel, 4031 Basel, Switzerland.
Mohamed A AdamDepartment of Surgery, University of California San Francisco, San Francisco, CA 94143, USA.
Alexander WilhelmDepartment of Surgery, Clarunis-St. Clara Hospital & University Hospital Basel, 4031 Basel, Switzerland.ORCID 0000-0001-9496-0237

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

chemotherapyNCDBoverall survivalpropensity score matchingretroperitoneal sarcoma

Identifiers

PMID40563581
PMCPMC12190581

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.